Remove Data Remove Events Remove Pets Remove Treatment
article thumbnail

Six Things You Need to Know About CBD and Other Hemp-containing Pet Products

Cannabis Law Report

The trend toward state-level legalization of cannabis has led to a surge in cannabis-derived products and a continually evolving market with many types of cannabis products for people as well as their pets. Are any CBD and hemp-containing products legal for use in pet products? Who’s responsible for regulating CBD in pet products?

Pets 105
article thumbnail

FDA Publish Article “5 Things to Know about Delta-8 Tetrahydrocannabinol – Delta-8 THC”

Cannabis Law Report

They may be marketed in ways that put the public health at risk and should especially be kept out of reach of children and pets. This deceptive marketing of unproven treatments raises significant public health concerns because patients and other consumers may use them instead of approved therapies to treat serious and even fatal diseases.

THC 105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Frost Brown Todd: Take Heed: FDA & CDC Release Health Alerts About Delta-8 THC

Cannabis Law Report

The major concerns noted were adverse events following consumption (many from inadvertent intoxication), marketing to and use by minors, and the potential presence of harmful by-products and unsafe manufacturing practices. The FDA has received adverse event reports involving delta-8 THC-containing products. CDC Health Alert.

THC 52
article thumbnail

FDA Cites Five Companies for Illegally Selling Delta-8 THC and CBD Products

Cannabis Law Report

FDA states it has received 104 reports of adverse events in patients who consumed delta-8 THC products between December 1, 2020 and February 28, 2022. The agency stated that it has received numerous adverse event reports involving delta-8 THC-containing products. CBD oil is an effective natural treatment for OCD.”. “If

THC 52
article thumbnail

Mondaq – United States: Agency Activity Signals Regulatory Agenda, Enforcement Priorities, And Litigation Risk For CBD Products

Cannabis Law Report

2 At the conclusion of the meeting, FDA stated that it would form an internal working group to study data gaps relating to CBD. As indicated by FDA’s recent announcement, the collection of data about the risks and benefits of CBD remains a priority for the agency. FDA submitted this report last week, as is discussed below.

CBD 45
article thumbnail

CBD Market Report

Project CBD

HerbalGram, the acclaimed quarterly journal of the American Botanical Council, recently published its 2021 “Herb Market Report,” which included data on sales of CBD as an herbal ingredient in mainstream and natural retail channels in the United States. Consumers spent roughly $31.3 increase in annual sales. Accessed July 25, 2021.

CBD 144
article thumbnail

Newsom Stymies Recall, Remains California Governor

SpeedWeed

In its warning statement, “5 Things to Know About Delta-8 Tetrahydrocannabinol,” the FDA said delta-8 has “serious health risks,” and it has not evaluated or approved delta-8 products for safe use in any context, specifically calling to keep the cannabinoid out of reach of children and pets. View original article.